Does Grupo Cibest (CIB) have what it takes to be a top stock pick for momentum investors? Let's find out.

Does Cavco (CVCO) have what it takes to be a top stock pick for momentum investors? Let's find out.

(Refiles to correct story identifier metadata for some readers, no change ​to content of story) New York, Dec ‌3 () - Lower interest rates would likely eliminate the ‌need for a 50-year mortgage floated by President Donald Trump's administration to boost

Two of Wall Street’s biggest firms say the AI boom isn’t a bubble, arguing real spending and earnings support the stock market rally even as near-term risks emerge.

Shares of casual restaurant chain Portillo’s (NASDAQ:PTLO) fell in the morning session as market sentiment weakened despite a \\

Shares of freight delivery company XPO (NYSE:XPO) jumped 3.6% in the morning session after an analyst at Bank of America Securities maintained a 'Buy' rating on the stock and increased the price target. The analyst, Ken Hoexter, lifted the price target fr

Microsoft pairs double‑digit AI‑driven growth and massive cloud free cash flow with a 20‑plus‑year dividend streak and fortress balance sheet, which is why Wall Street and firms like Triumvirate view it as both an AI leader and one of the safest stocks to

Treasury Secretary Scott Bessent, who has been leading the interview process for the next Federal Reserve chair, stopped short on Wednesday of confirming that the job will go to National Economic Council Director Kevin Hassett.

Crude oil inventories in the United States increased by 600,000 barrels during the week ending November 28, after adding 2.8 million barrels in the week prior

March Euro currency futures present a buying opportunity on more price strength.

Recent performance sets the stage S&P Global (SPGI) has drifted lower over the past month, slipping about 1% and roughly 9% in the past 3 months, even as its long term growth story remains intact. See our latest analysis for S&P Global. At around $491 per

Safran’s latest stock narrative reflects a steady fair value target of €328.67, even as a slightly higher discount rate of 6.86% signals a marginally more cautious stance on risk. With revenue growth expectations holding firm at 10.82%, the updated view s

Xeris Biopharma Holdings has seen its narrative refreshed as analysts reaffirmed a consensus fair value estimate of $11.50 per share, while making only marginal tweaks to underlying assumptions. Backed by quarterly revenues that edged past expectations an

The world’s largest asset manager released its AI report with a bearish outlook on U.S. bonds and the country’s economy, and presented a bullish projection for crypto adoption.

Headline ADP Payrolls Number Comes in Negative.